UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~November~~December 242, 2016

Enhance Skin Products Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada

000-52755

84-1724410

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

50 West Liberty Street, Suite 880, Reno NV		80246
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (416) 306—2493

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~ITEM 4.01~~[ –] ~~Changes~~Soliciting inmaterial ~~Registrant’s~~pursuant ~~Certifying~~to ~~Accountant~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

a[ ] Pre-commencement communications pursuant to Rule 14d-2(b) ~~Resignation~~ ofunder ~~Seale~~the &Exchange ~~Beers,~~Act ~~CPAs~~(17 CFR 240.14d-2(b))

~~Enhance Skin~~[ ~~Products~~] ~~Inc.~~Pre-commencement ~~(the~~communications ~~“Company”)~~pursuant ~~was~~to ~~notified~~Rule ~~by its independent registered public accounting firm, Seale & Beers, CPAs~~ 13e-4(~~“Seale & Beers”~~c) ~~that~~under ~~it was being acquired by AMC Auditing, LLC. As a result, effective November 24, 2016 Seale & Beers resigned as~~ the ~~Company’s~~Exchange ~~independent~~Act ~~registered~~(17 ~~public~~CFR ~~accounting firm~~240.13e-4(c))

~~The~~Section ~~audit~~2 ~~reports~~– ofFinancial Seale & Beers on the financial statements for the past two years did not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that the audit report of Seale & Beers, dated July 21, 2016 on the consolidated financial statements of the Company as of and for the fiscal years ended April 30, 2016 and April 30, 2015 noted that the Company has minimal revenues, has negative working capital at April 30, 2016, has incurred recurring losses and recurring negative cash flow from operating activities and an accumulated deficit which raises substantial doubt about its ability to continue as a going concern and the audit report of Seale & Beers, dated July 23, 2015 on the consolidated financial statements of the Company as of and for the fiscal years ended April 30, 2015 and April 30, 2014 noted the Company has minimal revenues, has negative working capital at April 30, 2015, has incurred recurring losses and recurring negative cash flow from operating activities and an accumulated deficit which raises substantial doubt about its ability to continue as a going concern.Information

~~During~~Item ~~the~~2.01 ~~fiscal~~- ~~years~~Completion ~~ended April 30, 2016 and April 30, 2015, and the subsequent period through July 31, 2016, and in connection with the audit~~ of ~~the~~Acquisition ~~Company’s financial statements for such periods, there were no disagreements with Seale & Beers, on any matter of accounting principles~~ or ~~practices,~~Disposition financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Seale & Beers’ satisfaction, would have caused Seale & Beers to make reference to the subject matter of ~~the disagreement in its reports on the consolidated financial statements for such years.~~Assets

~~During~~On ~~the~~December ~~fiscal years ended April 30~~2, 2016, ~~and~~the ~~April~~Asset ~~30,~~Purchase ~~2015,~~Agreement ~~and~~ (the ~~subsequent~~“APA”) ~~period~~executed ~~through~~on ~~July~~October 311, 2016, ~~there~~between ~~were~~the noCompany, ~~reportable~~Integumen ~~events~~Inc., ~~within~~Integumen ~~the~~Limited, ~~meaning~~Donald ofNicholson ~~Item~~and ~~304(a)(1)(v)~~Samuel ofAsculai ~~Regulation~~was ~~S-K,~~completed. ~~other~~Pursuant ~~than~~to the ~~material~~APA, ~~weaknesses reported in~~ the Company~~’s Annual~~ ~~Reports~~has onsold ~~Form~~to ~~10-K~~Integumen Inc. ~~and~~substantially ~~Quarterly~~all ~~Reports~~of onits ~~Form~~assets ~~10-Q~~and ~~with~~certain ~~respect~~of toits ~~such periods~~liabilities.

The Company ~~has~~received ~~provided~~2,632,868 aordinary ~~copy~~shares ofin ~~this~~Integumen ~~Form~~Limited ~~8-K~~at toa ~~Seale~~price &of ~~Beers~~£1 ~~and~~per ~~requested~~share. ~~Seale~~This &comprised ~~Beers~~the tototal ~~furnish a letter as required~~consideration byof ~~Item~~£3,030,000 ~~304~~(~~a)(~~$3,840,525)* less assumed liabilities of ~~Regulation~~£320,209 ~~S-K.~~($416,272) Aand ~~copy~~the amount of ~~letter~~£76,923 ~~from~~($100,000) owing ~~Seale~~under &the ~~Beers~~secured ~~dated~~promissory ~~November~~note ~~24,~~issued ~~2016~~by isthe ~~attached~~Company ~~hereto~~to asIntegumen ~~Exhibit 16.1~~on toJuly ~~this~~7, ~~Report~~2016.

The APA provides that 80 per cent of the Consideration Shares should be issued on completion of the APA and the remaining 20 per cent. (bsubject to an adjustment depending on the value of the assumed liabilities) should be issued within 30 days of Admission of Integumen ~~Engagement~~to AIM. However, prior to completion of ~~AMC~~the ~~Auditing~~APA, ~~LLC~~the parties to the APA agreed upon the adjustment to the number of Consideration Shares to be issued to the Company by Integumen Limited and, consequently at completion, the Company was issued with 2,632,868 ordinary shares in full and final satisfaction of the obligations of Integumen Limited and Integumen, Inc to provide consideration to the Company for the acquisition of the business assets.

OnItem ~~November 24, 2016 (the “Engagement Date”), the Registrant’s Board of Directors approved the appointment of and engaged AMC Auditing, LLC, 8250 W~~3.02 ~~Charleston~~– ~~Blvd.,~~Unregistered ~~Suite~~Sales 100, Las Vegas, Nevada 89117, as the Registrant’s independent registered public accounting firm. During the Company’s fiscal years ended April 30, 2016 and April 30, 2015, and the subsequent period through the Engagement Date, the Company did not consult with, nor did anyone on its behalf consult with, AMC Auditing, LLC regarding either (1) the application of ~~accounting~~Equity principles to a specified transaction regarding the Company, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or (2) any matter regarding the Company that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and related instructions to Item 304 of Regulation S-K) or a reportable event (as defined in Item 304(a)(1)(v) of Regulation S-K).Securities

~~Item~~As ~~9.01.~~a ~~Financial~~result ~~Statements~~of completion of the APA, certain amounts owing to Mercuriali Limited, Samuel Asculai, Drasko Puseljic and ~~Exhibits~~Frode Botnevik became payable in shares of the Company and such shares were issued on December 2, 2016 as more particularly set out below.

The Company issued a total of 168,235,216 common shares to Mercuriali Ltd. This issuance comprised of (a) the issuance of 8,826,595 common shares in conversion of $33,188 of debt at $0.00376 per share under a Termination and Settlement Agreement dated July 12, 2010; (b) the issuance of 50,094,947 common shares in conversion of $188,357 of debt at $0.00376 per share under a Loan Agreement dated March 4, 2013, as amended September 20, 2013, March 3, 2014, September 29, 2015, January 22, 2016 and March 21, 2016 (the “Loan Agreements”); (c) the issuance of 71,232,222 common shares in conversion of $128,218 of debt at $0.0018 per share under the Loan Agreements; (d) the issuance of 27,261,111 common shares in conversion of $49,070 of debt at $0.0018 per ~~Exhibits~~share under a Consultancy Agreement dated March 5, 2013 as amended March 3, 2014, August 1, 2015, March 21, 2016, and October 1, 2016 (the “Mercuriali Consultancy Agreement”); and (e) the issuance of 10,820,340 common shares in conversion of $110,029 of debt at $0.01017 under the Mercuriali Consultancy Agreement.

The ~~following~~Company ~~exhibits~~issued ~~are~~a ~~filed~~total ~~herewith:~~of 20,558,939 common shares to Samuel Asculai. This issuance comprised of (a) the issuance of 16,333,333 common shares in conversion of $29,400 of debt at $0.0018 per share under a Consultancy Agreement at dated March 5, 2013 as amended March 3, 2014, August 1, 2015, March 21, 2016, and October 1, 2016 (the “Asculai Consultancy Agreement”); and (b) the issuance of 4,225,606 common shares in conversion of $42,969 of debt at $0.01017 per share under the Asculai Consultancy Agreement.

~~Exhibit~~The NoCompany issued a total of 31,213,859 common shares to Drasko Puseljic. This issuance comprised of (a) the issuance of 10,654,920 common shares in conversion of $40,062 of debt at $0.00376 per share under a Termination Agreement dated March 5, 2013; (b) the issuance of 16,333,333 common shares in conversion of $29,400 of debt at $0.0018 per share under an Employment Agreement dated March 5, 2013 as amended March 3, 2014, August 1, 2015, March 21, 2016, and October 1, 2016 (the “Puseljic Employment Agreement”); and (c) the issuance of 4,225,606 common shares in conversion of $42,969 of debt at $0.01017 per share under the Puseljic Employment Agreement.

16The Company issued a total of 2,447,458 common shares to Frode Botnevik. This issuance comprised of (a) the issuance of 1 ~~Letter~~,944,444 ofcommon ~~Seale~~shares ~~and~~in ~~Beers~~conversion of $3,500 ~~CPAs~~of debt at $0.0018 per share under a Directors Service Agreement dated ~~November~~August 241, 2015 as amended March 21, 2016 and October 1, 2016 (the “Botnevik Services Agreement”); and (b) the issuance of 503,013 common shares in conversion of $5,115 of debt at $0.01017 per share under the Botnevik Services Agreement.

The sale of all the securities set out above was made in reliance on the exemption from registration provided by Section 4(2) of the Securities Act of 1933.

The conversion price of $0.01017 is based on the estimated value of the consideration attributable to equity shareholders on a fully diluted basis in pounds sterling translated into US dollars at the closing sterling/dollar interbank rate on October 19, 2016. This price is subject to change based on any adjustments under the APA and the exchange rate at completion. Any adjustments to the number of shares to be issued will be made to the number of shares to be issued to related parties under the consultancy, employment and service agreements for services rendered after October 20, 2016.

On conversion of the above advances Mercuriali Limited and Dr. Asculai released all security held over all the assets of the Company as required by the APA.

*The UK Pound Sterling (£) amount of the total consideration amount have been converted into US dollars at the closing US$/£ sterling interbank spot rate on December 2, 2016 of 1.2675 for the convenience of readers.

The foregoing description of APA and the conversions does not purport to be complete and is qualified in its entirety by reference to the complete text of the APA, and the amendments to the Consulting Agreements, Employment Agreement and Services Agreement which were filed as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5 to the Company’s Current Report on Form 8-K filed on October 5, 2016 and Schedule 14C Information Statement filed October 31, 2016 all of which are incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Enhance Skin Products Inc.

	By:	/s/ Donald Nicholson
		Donald Nicholson
		President/CEO, Principal Executive Officer

Dated: ~~November~~December 285, 2016

Filing Compare · Enhance Skin Products Inc